Purchase Order 36C25723P0278
- Not listed
- Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostic solutions, has been awarded a $685,337.42 delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 8 for performance in Castleton, Indiana. The contract, awarded October 1, 2025, with completion targeted for April 30, 2026, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued as a child contract under Roche Diagnostics' existing...
- Roche Diagnostics Corporation was awarded a $160,909.25 firm fixed price purchase order by Veterans Integrated Service Network 17 (VISN 17), a civilian component of the Department of Veterans Affairs, on September 1, 2022. The contract, which is not designated as a set-aside, is scheduled for completion by August 31, 2025, with the place of performance located in Castleton, Indiana. This purchase order represents a child contract award, indicating it is likely issued under a larger vehicle...
- This is a federal contract award to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $265,687.25, is a Delivery Order awarded by the Department of Veterans Affairs (VA) for the Veterans Integrated Service Network 9. It is a firm fixed-price contract with a period of performance ending on September 30, 2026. The contract does not have a...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded a $186,000.00 purchase order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, for laboratory diagnostics related to cancer treatment. The firm-fixed-price contract has a completion date of December 31, 2020 and does not use a small business set-aside. Roche Diagnostics has extensive experience providing clinical chemistry analyzers, reagents, test kits, and...
- The Department of Veterans Affairs' Veterans Integrated Service Network 23 awarded Roche Diagnostics Corporation a delivery order valued at $190,494.82 on October 11, 2024, for microbiology reagents during the base period, with an ultimate completion date of September 30, 2025. This firm fixed-price contract, which includes a deobligation component, will be performed in Castleton, Indiana. The award carries no set-aside designation and represents the government's procurement of essential...
- Roche Diagnostics Corporation has been awarded a $866.67K delivery order by Veterans Integrated Service Network 20, a civilian component of the Department of Veterans Affairs, with a firm fixed-price structure. The contract covers laboratory reagents and consumables priced on a cost-per-reportable-result basis, with an ultimate completion date of February 10, 2026. The award represents a child contract under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration...
- Roche Diagnostics Corporation received a $353,330.46 firm fixed-price Blanket Purchase Agreement (BPA) call order from Veterans Integrated Service Network 17 (VISN 17) for molecular laboratory services, with performance at its Castleton, Indiana facility. The contract was awarded on May 20, 2024, with an ultimate completion date of May 19, 2025. This award is a child contract under the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) master schedule, enabling the...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 16, awarded a delivery order contract to Roche Diagnostics Corporation on October 16, 2024, for the supply of reagents and related diagnostic materials. This firm fixed-price delivery order, valued at $194,832.96 with completion targeted by November 15, 2026, represents a child contract under a larger indefinite delivery vehicle. The work will be performed in Castleton, Indiana. No small business set-aside was applied...
- This is a federal contract award to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $875,220.60, is a Firm Fixed Price Delivery Order awarded by the U.S. Department of Veterans Affairs (VA) through the Veterans Integrated Service Network 9. The contract is not set aside and will run through September 30, 2023. Roche Diagnostics is a global...
- Roche Diagnostics Corporation received a $548,492.46 firm fixed-price purchase order from Veterans Integrated Service Network 22 (VISN 22), a civilian component of the Department of Veterans Affairs, for reagents and consumables. The contract was awarded on December 5, 2025, with an ultimate completion date of June 4, 2026, and will be performed at the contractor's facility in Castleton, Indiana. This award carries no set-aside designation, indicating open competition in the federal marketplace....
The Department of Veterans Affairs, Veterans Integrated Service Network 17, awarded a $27.3K firm fixed-price purchase order to Roche Diagnostics Corporation for diagnostic services on August 15, 2023, with an ultimate completion date of August 14, 2028. The contract, which was not set aside for small business or other designated categories, is based on a Special Notice solicitation posted in January 2023. Roche Diagnostics will perform services at its facility in Castleton, Indiana, delivering diagnostic solutions that support the VA's healthcare mission for veterans across the network's service area. Roche Diagnostics Corporation, a foreign-owned manufacturer and global leader in in vitro diagnostics, reagents, and laboratory instruments, was selected through open competition. The company maintains an extensive portfolio of federal contracts primarily with the VA and Defense Health Agency, providing comprehensive laboratory testing services, clinical chemistry analyzers, molecular diagnostic equipment, and specialized reagents. This purchase order represents a child contract under Roche's existing federal contract vehicles, leveraging pre-negotiated pricing and terms to enable efficient acquisition of critical diagnostic technologies that support medical research, disease detection, and patient care within the veterans healthcare system.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
J066--NEW - GenMark Svc | 36C25723Q0275 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 | Special Notice 1/1 | 1/7/23, 12:05 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Other Administrative Action | ($7k) | 12/22/25 | |
| P00001 | Exercise an Option | $6.8k | 5/29/24 | |
| Not listed | Not listed | $6.8k | 4/26/23 |